ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,777Medicare Part D Prescriptions Filled, Including Refills

Rank: 215 out of 2116

$596K Total Retail Price of All Prescriptions

Rank: 413 out of 2116

386 Patients Receiving at Least One Drug in Part D
96% Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Jersey
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 386 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

6% of this provider’s 386 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $77 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
FUROSEMIDE 333 328* 53 1 6
AMLODIPINE BESYLATE 332 327* 68 2 1
LEVOTHYROXINE SODIUM 311 306* 65 3 4
DONEPEZIL HCL 288 283* 37 4 22
POTASSIUM CHLORIDE 279 279 40 5 25
METOPROLOL TARTRATE 275 270* 54 6 10
FAMOTIDINE* 257 257 39 7 36
WARFARIN SODIUM 246 246 27 8 11
OMEPRAZOLE 229 203 35 9 5
SIMVASTATIN 211 206* 45 10 2
ATORVASTATIN CALCIUM 184 179* 38 11 3
CLOPIDOGREL 181 176* 27 12 12
HYDROCODONE-ACETAMINOPHEN 180 175* 18 S3 13 51
LISINOPRIL 178 173* 43 14 7
METOPROLOL SUCCINATE 178 167 34 14 9
ALPRAZOLAM 159 159 36 B 16 14
SERTRALINE HCL 153 153 28 17 28
HYDROCHLOROTHIAZIDE 132 127* 25 18 13
DIOVAN 132 127* 24 18 16
CYMBALTA 120 120 12 20 49
LOSARTAN POTASSIUM 116 111* 25 21 15
TAMSULOSIN HCL 109 109 22 22 27
ESCITALOPRAM OXALATE 104 99* 17 23 33
NAMENDA 102 <11 <11 24 24
PREDNISONE 100 100 28 25 55
GABAPENTIN 99 99 16 26 23
LORAZEPAM 92 87* 22 B 27 38
POLYETHYLENE GLYCOL 3350 88 88 13 28 81
QUETIAPINE FUMARATE 85 71 12 A 29 58
DIGOX 82 82 12 30 92
TRAMADOL HCL 80 80 16 31 30
ATENOLOL 76 76 14 32 26
DILTIAZEM 24HR CD 76 76 17 32 133
ADVAIR DISKUS 75 75 13 34 41
ZOLPIDEM TARTRATE 74 74 17 35 17
CARBIDOPA-LEVODOPA 74 <11 <11 35 113
FLUTICASONE PROPIONATE 74 74 20 35 43
PRANDIN 73 68* 16 38 160
LANTUS SOLOSTAR 73 <11 <11 38 70
MIRTAZAPINE 73 73 14 38 45
LEVETIRACETAM 70 <11 <11 41 76
CLONIDINE HCL 66 61* 11 42 69
PANTOPRAZOLE SODIUM 63 63 20 43 29
PRAVASTATIN SODIUM 62 62 15 44 19
AGGRENOX 62 <11 <11 44 208
AZITHROMYCIN 61 56* 47 46 35
VERAPAMIL ER 60 <11 <11 47 169
METFORMIN HCL 59 54* 11 48 8
TRAMADOL HCL-ACETAMINOPHEN 59 59 16 48 104
DICLOFENAC SODIUM 57 57 12 50 162
OXYBUTYNIN CHLORIDE ER 56 <11 <11 51 140
RISPERIDONE 56 <11 <11 A 51 60
PAROXETINE HCL 54 <11 <11 53 78
FENTANYL 52 <11 <11 S2 54 82
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.